Meia Yevi Setyawati, Nisa Rahmadila Rizqi, Arham Agusto, Syifa Al Haninah, Aninditya Ayu Oktaviani, Abdulrohim E-sor, Hamzah Al-Haqqoni

Sharia Pharmacy: Ethical Perspectives on Generic Drug Use in Contemporary Medical Practice

Introduction

Sharia pharmacy: ethical perspectives on generic drug use in contemporary medical practice. Explore Sharia pharmacy ethics on generic drug use, halal compliance, and accessibility in modern medical practice. Enhances ethical integrity for Muslim communities.

Abstract

Objective: To analyze the relationship between modern pharmaceutical practices and Sharia principles, focusing on the halal compliance of generic drugs, and to explore how these principles enhance accessibility, fairness, and ethical integrity in healthcare. Theoretical framework: This study is grounded in Sharia pharmacy principles, emphasizing Islamic ethics (halal, fairness, and social responsibility) as well as the balance of benefits and risks in modern pharmaceutical practices. Literature review: The review includes studies on the development and use of generic drugs in Indonesia, the integration of halal certification in pharmaceutical production, and the ethical considerations in Sharia-compliant healthcare systems. Methods: A qualitative approach analyzing regulations, halal certification standards, and ethical guidelines in Sharia pharmacy, combined with a conceptual analysis of the alignment between generic drug practices and Islamic values. Results: The findings highlight that generic drugs, when produced according to halal principles, provide both affordability and ethical assurance. The study confirms the importance of halal certification to ensure the suitability of pharmaceutical products for the Muslim community and the alignment of modern practices with Sharia ethics. Implications: The study suggests the need for stronger collaboration between pharmaceutical companies, halal certification bodies, and healthcare professionals to ensure the integrity and accessibility of Sharia-compliant medicines in Indonesia. Novelty: This research uniquely bridges the gap between modern pharmaceutical practices and Sharia ethics, offering a comprehensive perspective on how generic drugs can fulfill both economic and religious requirements in the healthcare system.

Review

The submitted paper, "Sharia Pharmacy: Ethical Perspectives on Generic Drug Use in Contemporary Medical Practice," addresses a timely and significant topic at the confluence of modern healthcare and Islamic ethics. The authors meticulously aim to analyze the relationship between contemporary pharmaceutical practices, particularly the use of generic drugs, and Sharia principles, with a specific focus on ensuring halal compliance. The study is theoretically well-grounded, emphasizing Islamic ethics such as halal, fairness, and social responsibility, and explicitly seeks to demonstrate how these principles can bolster accessibility, fairness, and ethical integrity within healthcare systems. The methodology employed is qualitative, involving a comprehensive analysis of relevant regulations, halal certification standards, and ethical guidelines within Sharia pharmacy. This is coupled with a conceptual analysis to robustly assess the alignment between generic drug practices and core Islamic values. The findings unequivocally highlight that generic drugs, when produced in strict adherence to halal principles, offer significant advantages in terms of both affordability and ethical assurance. Crucially, the research underscores the indispensable role of halal certification in ensuring the suitability of pharmaceutical products for Muslim communities, thereby confirming the successful integration of modern practices with Sharia ethics, particularly in the Indonesian context. This research distinguishes itself by uniquely bridging the gap between modern pharmaceutical practices and Sharia ethics, offering a comprehensive and novel perspective on how generic drugs can effectively meet both economic and religious requirements in healthcare. The practical implications are clear and impactful, advocating for stronger collaborative efforts among pharmaceutical companies, halal certification bodies, and healthcare professionals to ensure the integrity and accessibility of Sharia-compliant medicines in Indonesia. This study serves as a vital contribution to pharmaceutical ethics and public health, providing a robust framework for ethical pharmaceutical development and accessibility that resonates deeply with the values of Muslim populations globally.

Full Text

Comments

You need to be logged in to post a comment.